mean
total
symptom
sever
score
subject
experiment
rhinoviru
cold
peak
h
viral
inocul
also
total
symptom
score
natur
rhinoviru
nonrhinoviru
cold
peak
day
ill
longterm
noncompens
epidemiolog
studi
contrast
mean
total
symptom
score
compens
patient
receiv
placebo
natur
cold
treatment
trial
peak
day
comparison
day
indic
score
symptom
report
occur
day
natur
cold
treatment
trial
correspond
experiment
cold
score
symptom
report
h
viral
inocul
comparison
frequenc
cumul
distribut
score
group
indic
natur
cold
treatment
trial
longer
durat
report
mean
total
symptom
sever
score
would
captur
experiment
cold
h
inocul
exclud
natur
cold
day
ill
histori
given
compens
patient
natur
cold
treatment
trial
inaccur
investig
conduct
treatment
trial
involv
patient
natur
cold
perceiv
difficulti
enrol
patient
earli
stage
ill
cold
ill
shortliv
selflimit
averag
total
cold
symptom
score
indic
peak
sever
h
initi
experiment
infect
decreas
undesir
enrol
patient
therapi
trial
cold
exce
h
durat
potenti
maximum
therapeut
benefit
lost
also
situat
benefici
effect
associ
treatment
compar
statu
ill
control
subject
symptom
sever
improv
spontan
rhinoviru
challeng
model
viru
inocul
nose
suscept
volunt
produc
experiment
induc
infect
therefor
incub
period
infect
ill
known
subject
enrol
challeng
studi
payment
assur
thu
monetari
incent
falsifi
symptom
model
treatment
start
earli
phase
ill
benefici
magnitud
effect
accur
measur
contrast
possibl
know
infect
begin
natur
cold
determin
certainti
durat
ill
time
patient
present
enrol
investig
depend
timeli
accuraci
symptom
report
patient
mean
verifi
accuraci
inform
thu
element
uncertainti
alway
present
result
treatment
trial
involv
patient
natur
occur
cold
studi
conduct
determin
whether
symptom
data
collect
previou
rhinoviru
challeng
studi
onset
infect
ill
known
provid
clue
determin
durat
ill
patient
natur
cold
symptom
pattern
subject
experiment
cold
compar
patient
natur
cold
analysi
provid
inform
may
use
moreaccur
determin
time
onset
natur
cold
data
came
earlier
studi
experiment
natur
cold
studi
subject
report
presenc
absenc
symptom
other
sever
cold
symptom
quantifi
modifi
method
jackson
studi
peak
symptom
score
maximum
percentag
patient
symptom
compar
found
occur
day
symptom
evalu
use
jackson
method
sneez
rhinorrhea
nasal
obstruct
sorescratchi
throat
cough
headach
malais
chilli
subject
ask
grade
sever
symptom
absent
mild
moder
sever
experi
sever
daili
basi
daili
total
symptom
sever
score
obtain
ad
sever
score
individu
symptom
diagnosi
cold
made
subject
minimum
total
symptom
score
day
observ
believ
cold
andor
report
rhinorrhea
day
first
analysi
time
peak
express
total
individu
symptom
compar
use
result
studi
experiment
cold
studi
natur
cold
next
data
subject
experiment
cold
receiv
placebo
repres
rhinoviru
challeng
studi
compar
data
patient
receiv
placebo
repres
natur
cold
clinic
trial
symptom
sever
subject
experiment
natur
cold
group
quantifi
modifi
jackson
method
patient
natur
cold
instruct
report
enrol
treatment
recognit
first
symptom
believ
might
repres
onset
cold
data
group
compar
mean
total
individu
symptom
sever
day
time
report
hour
viru
inocul
subject
experiment
cold
day
ill
basi
histori
given
patient
natur
cold
data
studi
use
construct
histogram
compar
rang
sever
day
individu
total
symptom
score
subject
perform
analysi
time
develop
maximum
total
symptom
score
guidelin
human
experiment
follow
protocol
consent
form
approv
human
investig
committe
univers
virginia
charlottesvil
written
inform
consent
obtain
subject
enrol
studi
analysi
mean
total
sever
symptom
score
total
symptom
sever
score
analyz
correl
count
data
gener
estim
equat
model
paramet
margin
fix
effect
estim
maximum
likelihood
gener
linear
model
neg
binomi
link
function
variancecovari
paramet
estim
unstructur
variancecovari
matrix
form
use
huber
white
estim
independ
variabl
includ
index
distinguish
patient
whose
data
deriv
natur
cold
studi
patient
whose
data
deriv
experiment
challeng
studi
patient
indic
also
includ
distinguish
point
time
symptom
evalu
experiment
natur
cold
studi
experiment
studi
h
h
h
h
viru
inocul
natur
cold
day
ill
determin
patient
histori
final
compon
model
indic
includ
estim
studi
group
time
interact
time
point
time
point
comparison
mean
total
symptom
sever
score
group
conduct
via
linear
contrast
statist
infer
determin
magnitud
wald
x
statist
reject
null
hypothesi
effect
p
level
signific
confid
interv
construct
group
mean
ratio
group
mean
base
wald
normal
approxim
limit
determin
level
confid
statist
comput
perform
proc
genmod
procedur
sa
softwar
version
sa
institut
analysi
distribut
total
symptom
sever
score
symptom
sever
score
frequenc
distribut
experiment
challeng
studi
compar
day
symptom
sever
score
frequenc
distribut
natur
cold
studi
use
nonparametr
logrank
x
test
logrank
test
use
evalu
whether
empir
cumul
distribut
ecd
score
respect
studi
group
equal
correspond
point
time
valu
ecd
determin
empir
distribut
function
parecdf
p
score
score
n
ticular
observ
score
valu
ecdf
repres
proport
observ
symptom
sever
score
valu
less
equal
particular
score
empir
distribut
function
evalu
observ
symptom
sever
score
particular
group
provid
estim
cumul
distribut
score
studi
popul
repres
partic
b
percentag
subject
symptom
given
day
patient
receiv
monetari
compens
c
maximum
percentag
patient
given
symptom
peak
score
symptom
day
viru
diagnost
studi
perform
ular
group
ci
construct
estim
upper
lower
bound
popul
cumul
distribut
base
bonferroni
criterion
valu
repres
type
error
rate
valu
k
repres
number
uniqu
cut
point
cumul
probabl
evalu
bonferroni
confid
limit
use
attain
ci
specifi
coverag
probabl
requir
take
account
inher
correl
success
valu
ecd
type
error
rate
use
ci
construct
therefor
overal
simultan
coverag
probabl
statist
comput
analysi
distribut
total
symptom
sever
score
perform
splu
version
insight
mean
total
symptom
sever
score
adult
experiment
rhinoviru
cold
peak
day
studi
tabl
longterm
epidemiolog
studi
natur
cold
caus
rhinoviru
virus
rhinoviru
adult
compens
percentag
patient
symptom
also
peak
day
contrast
cold
treatment
trial
involv
natur
cold
unknown
etiolog
patient
paid
particip
percentag
subject
symptom
mean
total
symptom
sever
score
peak
day
regard
individu
cold
symptom
day
peak
sever
preval
instanc
subject
experiment
rhinoviru
cold
patient
natur
cold
epidemiolog
studi
sever
rhinorrhea
peak
day
instanc
except
natur
rhinoviru
cold
preval
peak
day
preval
nasal
obstruct
peak
day
group
sever
sneez
peak
day
experiment
cold
group
preval
peak
day
rhinoviru
natur
cold
group
sever
sore
throat
peak
day
experiment
cold
group
except
one
peak
day
sever
cough
peak
day
experiment
cold
group
preval
peak
day
natur
rhinoviru
nonrhinoviru
cold
respect
sever
headach
malais
peak
day
group
contrast
individu
symptom
peak
sever
day
patient
clinic
trial
except
nasal
obstruct
cough
peak
day
one
instanc
comparison
mean
total
individu
symptom
sever
score
day
mean
total
symptom
sever
score
subject
experiment
cold
ci
h
viru
inocul
figur
contrast
mean
total
symptom
sever
score
patient
earli
natur
cold
ie
earli
onset
first
symptom
time
present
enrol
treatment
day
ci
repres
increas
ci
increas
total
p
symptom
score
mean
experiment
cold
group
h
viru
challeng
mean
total
symptom
score
experiment
cold
group
increas
ci
wherea
day
score
natur
cold
group
decreas
ci
result
similar
score
chang
mean
total
symptom
score
p
p
group
opposit
direct
time
period
hday
hday
rate
chang
substanti
differ
subsequ
period
p
hday
hday
rate
improv
symptom
similar
group
wherea
p
p
hday
hday
rate
improv
greater
experiment
cold
group
p
p
determin
whether
patient
treatment
trial
natur
cold
report
enrol
later
instruct
total
symptom
score
group
compar
shift
score
natur
cold
group
forward
h
compens
suspect
delay
report
data
point
repres
score
time
report
enrol
day
natur
cold
studi
shift
day
day
day
et
cetera
figur
mean
symptom
score
natur
cold
group
report
day
align
experiment
mean
symptom
score
adjust
mean
symptom
score
h
experiment
cold
group
compar
mean
symptom
score
day
natur
cold
group
rate
p
p
decreas
mean
total
symptom
score
h
h
experiment
cold
group
similar
rate
decreas
total
mean
symptom
score
natur
cold
group
day
day
similarli
mean
total
p
p
symptom
score
experiment
cold
group
h
compar
mean
total
symptom
score
natur
cold
group
day
rate
decreas
mean
p
p
total
symptom
score
h
h
experiment
cold
group
greater
ci
greater
rate
decreas
mean
total
p
symptom
score
natur
cold
group
day
h
mean
total
symptom
score
experiment
cold
group
significantli
less
p
p
mean
symptom
score
natur
cold
group
day
mean
score
individu
symptom
also
compar
experiment
natur
cold
group
figur
comparison
first
made
valu
h
viru
inocul
experiment
cold
group
day
natur
cold
group
instanc
score
experiment
cold
group
increas
interv
h
h
viru
inocul
contrast
natur
cold
group
score
symptom
decreas
day
day
singl
except
score
nasal
obstruct
slight
increas
day
score
natur
cold
group
shift
forward
correspond
postinocul
score
experiment
cold
group
curv
group
becam
similar
largest
discrep
sneez
cold
score
experiment
cold
group
natur
cold
group
increas
hday
h
day
cough
cold
score
natur
cold
group
decreas
score
experiment
cold
group
increas
period
howev
cough
score
increas
group
next
period
expect
previou
cold
studi
comparison
frequenc
cumul
distribut
total
symptom
sever
score
frequenc
distribut
total
symptom
sever
score
experiment
natur
cold
group
analyz
figur
use
calcul
ecd
total
symptom
score
experiment
natur
cold
group
without
shift
score
natur
cold
group
forward
h
figur
shift
ecd
symptom
score
experiment
cold
group
h
differ
ecd
symptom
score
natur
cold
group
day
tendenc
observ
higher
symptom
score
natur
cold
group
experiment
cold
group
examin
symptom
score
h
p
day
hday
hday
show
differ
group
ecd
respect
p
p
p
p
p
p
forward
shift
natur
cold
group
score
h
differ
score
natur
cold
group
ecd
day
experiment
cold
group
ecd
h
similarli
symptom
score
ecd
p
p
natur
cold
group
day
compar
symptom
score
ecd
experiment
cold
group
h
day
natur
cold
group
show
higher
p
p
symptom
score
experiment
cold
group
p
p
probabl
reflect
underreport
symptom
volunt
anxiou
releas
isol
motel
estim
total
symptom
sever
score
cumul
probabl
distribut
hday
estim
made
total
symptom
sever
score
cumul
probabl
distribut
experiment
cold
group
h
natur
cold
group
day
tabl
figur
vertic
bar
figur
repres
ci
estim
studi
popul
cumul
distribut
particular
total
symptom
score
cut
point
highest
individu
total
symptom
score
experiment
cold
group
h
highest
score
natur
cold
group
day
although
maximum
score
differ
greatli
middl
distribut
group
overlap
score
natur
cold
group
rang
wherea
experiment
cold
group
rang
experiment
cold
group
subject
total
estim
cumul
probabl
observ
total
symptom
sever
score
tss
magnitud
less
equal
specifi
total
symptom
sever
score
symptom
score
h
inocul
viru
contrast
patient
natur
cold
group
total
symptom
sever
score
day
report
ill
rate
decreas
total
symptom
score
rel
score
day
patient
placebo
group
natur
cold
trial
divid
group
basi
sever
total
symptom
score
day
score
group
adjust
baselin
figur
rate
decreas
mean
total
symptom
score
next
day
patient
day
score
much
pronounc
patient
group
suggest
individu
highest
present
score
differ
individu
group
regard
characterist
report
ill
sever
symptom
score
day
highli
unusu
shown
cumul
probabl
score
day
basi
data
experiment
cold
group
tabl
peopl
common
cold
tradit
portray
tender
red
nose
drip
mucu
act
sneez
howev
mani
patient
activ
cold
may
show
object
manifest
ill
unless
seen
period
episod
sneez
nose
blow
cough
especi
true
earli
stage
cold
optimum
time
begin
treatment
object
sign
earli
cold
usual
lack
clinic
trial
cold
treatment
reli
primarili
subject
data
obtain
histori
patient
symptom
score
advantag
measur
patient
morbid
relief
one
primari
goal
therapi
howev
symptom
score
disadvantag
depend
accuraci
histori
studi
suggest
patient
natur
cold
report
enrol
treatment
later
cours
ill
indic
symptom
histori
sever
possibl
reason
experiment
cold
incub
period
h
therefor
treatment
start
h
viru
inocul
ill
h
durat
start
treatment
hand
natur
cold
may
begin
earli
one
day
patient
might
report
enrol
treatment
afternoon
next
day
instanc
cold
accept
day
durat
actual
progress
h
second
monetari
incent
particip
cold
studi
affect
accuraci
histori
given
patient
cold
treatment
studi
potenti
enrolle
prospect
maintain
daili
symptom
diari
durat
ill
report
histori
given
time
present
enrol
treatment
day
shorter
given
written
record
symptom
diari
patient
situat
patient
heatedli
deni
inaccuraci
histori
demand
enrol
studi
receiv
payment
greater
concern
suspicion
individu
may
complet
falsifi
ill
gain
entranc
studi
financi
incent
issu
viru
challeng
studi
volunt
assur
payment
regardless
outcom
particip
reason
delay
enrol
includ
patient
honest
doubt
whether
cold
begin
preoccupi
daili
activ
notic
earli
mild
symptom
howev
peopl
recogn
earli
cold
symptom
one
studi
show
patient
natur
cold
interv
initi
symptom
individu
knew
cold
h
present
studi
clinic
characterist
experiment
rhinoviru
cold
known
durat
use
benchmark
compar
characterist
ill
report
natur
cold
clinic
trial
experiment
cold
use
comparison
met
modifi
jackson
criteria
use
experiment
rhinoviru
cold
benchmark
justifi
earlier
work
shown
natur
rhinoviru
cold
report
longterm
epidemiolog
studi
financi
incent
similar
clinic
characterist
experiment
rhinoviru
cold
also
epidemiolog
studi
cite
show
clinic
characterist
natur
cold
rhinoviru
posit
similar
clinic
characterist
rhinoviru
neg
figur
estim
cumul
probabl
distribut
total
symptom
score
day
ill
natur
cold
h
inocul
experiment
cold
vertic
bar
ci
estim
cumul
distribut
studi
popul
particular
total
symptom
score
cut
point
use
experiment
cold
benchmark
shown
mean
total
symptom
score
day
higher
expect
consider
proport
patient
natur
cold
treatment
trial
suggest
cold
longer
durat
report
treatment
studi
analyz
use
prospect
surveil
cold
symptom
enrol
studi
done
problem
late
enrol
may
wors
also
suggest
may
fabric
symptom
suggest
support
find
patient
highest
score
day
unusu
rapid
resolut
symptom
compar
patient
lower
score
day
use
experiment
cold
benchmark
probabl
score
magnitud
would
report
h
onset
infect
altern
explan
high
score
repres
ill
due
virus
influenza
viru
adenoviru
studi
conduct
influenza
epidem
would
unusu
symptom
influenza
acut
respiratori
diseas
due
adenoviru
resolv
rapidli
report
total
symptom
score
probabl
distribut
h
experiment
cold
day
natur
cold
show
symptom
sever
score
h
viru
inocul
captur
experiment
cold
exclud
natur
cold
report
occur
day
ill
futur
natur
cold
treatment
trial
may
use
use
day
total
symptom
score
exclus
criterion
help
achiev
enrol
patient
earli
cold
elimin
bogu
case
ill
addit
investig
may
want
consid
enrol
patient
h
first
recognit
possibl
cold
symptom
use
cutoff
enrol
may
requir
treatment
placebo
suppli
avail
particip
resid
natur
cold
studi
also
problem
complianc
take
medic
patient
natur
cold
studi
report
primarili
colleg
student
accur
inform
may
collect
older
respons
popul
use
previou
studi
addit
virolog
test
natur
cold
studi
solv
problem
yield
test
satisfactori
rhinoviru
good
cold
virus
coronaviru
also
viral
test
provid
inform
durat
ill
other
recent
comment
underreport
fabric
inform
medic
histori
import
better
understand
phenomenon
present
studi
use
histori
subject
natur
experiment
cold
inv
tigat
problem
find
indic
may
possibl
improv
clinic
trial
involv
patient
natur
cold
use
entri
criteria
base
predetermin
valu
present
total
symptom
score
